Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesUtilities of the EQ-5D: Transferable or Not
PharmacoEconomics, 09/30/09
Knies S et al. – All results indicate that the differences between the EQ–5D value sets are considerable and should not be ignored. The differences can largely be explained by methodological differences in the valuation studies. The remaining differences may reflect cultural dissimilarities between countries.
Related Articles
Quality of life and depression among metastatic breast cancer patients
Medical Oncology, 10/05/09
Relevance Score: 82%
The Impact of Differences in EQ-5D and SF-6D Utility Scores on the Acceptability of Cost–Utility Ratios: Results across Five Trial-Based Cost-Utility Studies
Value in Health, 11/11/09
Relevance Score: 80%
Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome
Medical Decision Making, 10/27/09
Relevance Score: 80%
Responsiveness of the EQ-5D to HADS-identified anxiety and depression
Journal of Evaluation in Clinical Practice, 10/07/09
Relevance Score: 80%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin
Current Medical Research and Opinion, 12/11/09
Economic consequences of ACS-related rehospitalizations in the US
Current Medical Research and Opinion, 12/10/09
Out-of-pocket Prices of Opioid Analgesics in the United States, 1999–2004
Pain Medicine, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor